Medical Researchers: Who Else But NVAX Can Do Multi-valent | NVAX Message Board Posts


NVAX   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  124633 of 220165  at  4/29/2021 10:44:54 AM  by

emichemich


Re: Medical Researchers: Who Else But NVAX Can Do Multi-valent

 
 Megan Tirrel asked MRNA's ceo Bancel if they will develop a version for india's variant - they are "thinking"
 
I bettcha that NVAX's Dr Patel is already doing trials in the lab and monkeys with India's  and the brazilian's variants.  The boost will need to be broad with all multivalents. 
 
 
Before long, we will need quadrivalents, or perhaps even octavalents some day. That will be extremely difficult if not impossible for mRNAs to pull off. $NVAX protein approach and dose sparing of nano-particle + Matrix-M ideally suited to meet this need. 5-10ug per variant.
Quote Tweet
Meg Tirrell
@megtirrell
·
Moderna's CEO tells us they may need to develop a version of their #covid19 targeted toward B.1.617 variant, circulating in India. twitter.com/SquawkCNBC/sta…
 


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 2  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board




Financial Market Data provided by
.
Loading...